COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Branimir Spassov, 99809

CCAAT/ENHANCER BINDING PROTEIN ALPHA (CEBPA) NEW MUTATIONS IDENTIFIED BY THE HEMATOLOGY OF FLORENCE

EHA Library, Vanessa Ponziani, 99810

REGULATION OF CD38 BY IRF4 IN CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Helen Marr, 99811

13Q DELETION IS PREDOMINANT CYTOGENETIC ABERRATION NEWLY AQUIRED DURING CHRONIC LYMPHOCYTIC LEUKEMIA COURSE IRRESPECTIVE OF DISEASE ACTIVITY AND TREATMENT STATUS

EHA Library, Jana Kotaskova, 99812

NOVEL NO-ASA DERIVATIVES ARE NEW PROMISING AGENTS IN THE THERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND SOLID CANCERS

EHA Library, Hanna Flamme, 99813

A RETROSPECTIVE CASE CONTROL STUDY ASSOCIATING CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS SPECIFIC ABERRATIONS WITH CERTAIN RISK FACTORS

EHA Library, Kalliopi Manola, 99814

CLINICAL COURSE OF LEPTOMENINGEAL INVOLVEMENT OF ACUTE MYELOID LEUKEMIA : 14-YEARS SINGLE CENTER EXPERIENCE

EHA Library, Ji Hyun Kwon, 99815

NEW PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC LEUKEMIA: PLASMA CCL3 (MIP-1Α)

EHA Library, Ayse Salihoglu, 99816

OVERALL SURVIVAL (OS) AND CLINICAL OUTCOMES IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR LOW-DOSE CYTARABINE (LDAC) IN THE AZA-AML-001 STUDY

EHA Library, John F.Seymour, 99817

CHARACTERIZATION OF NORMAL AND PATHOLOGICAL LYMPHOID POPULATIONS: VALIDATION OF A 10-COLORS FLOW CYTOMETRY PROTOCOL FOR ROUTINE DIAGNOSIS

EHA Library, Lauren Rigollet, 99818

CHEMOTHERAPY EXPOSURE AND SURVIVAL AMONG PATIENTS DIAGNOSED WITH CHRONIC LYMPHOID LEUKEMIA

EHA Library, Patience Musingarimi, 99819

REAL-WORLD OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION

EHA Library, Nicole Lamanna, 99820

MODELING THE EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND WALDENSTROM'S MACROGLOBULINEMIA (WM) IN FRANCE

EHA Library, Xavier Troussard, 99822

CLINICAL FEATURES AND OUTCOMES OF HYPOCELLULAR ACUTE MYELOID LEUKEMIA IN ADULTS: KOREAN AML REGISTRY DATA

EHA Library, Ik-Chan SONG, 99823

REDUCED-INTENSITY TRANSPLANTATION AS A PART OF STANDARD TREATMENT STRATEGY IN PATIENTS AGED 60 TO 70 YEARS WITH ACUTE MYELOID LEUKEMIA – SINGLE CENTRE EXPERIENCE.

EHA Library, Michal Karas, 99824

THE OCCURRENCE OF OTHER MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Milena TodorovicBalint, 99825

THE DNMT3A R882 MUTATION WITH FLT3-ITD POSITIVITY IS AN EXTREMELY POOR PROGNOSTIC FACTOR IN PATIENTS WITH NORMAL KARYOTYPE AML AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Hyeoung-Joon Kim, 99826

RETROSPECTIVE EVALUATION OF 83 PATIENTS WITH HAIRY CELL LEUKEMIA TREATED WITH 3 DIFFERENT TREATMENT MODALITIES IN THE LAST TWO DECADES: A SINGLE CENTER EXPERIENCE

EHA Library, Seniz Ongoren Aydin, 99827

DETECTION OF BCR-ABL GENE MUTATIONS IN CHRONIC MYELOID LEUKEMIA USING SENSITIVE LOW-DENSITY MICROARRAY APPROACH

EHA Library, Tatiana Nasedkina, 99828

SERUM CHEMOKINES AND CYTOKINES IN CLL PATIENTS TREATED WITH DUVELISIB, AN ORAL DUAL INHIBITOR OF PI3K-DELTA,GAMMA

EHA Library, Mark Douglas, 99829

CD26 ANTIGEN IS SPECIFIC FOR LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA AND DISTINGUISHES PATIENT GROUPS WITH DIFFERENT RATIOS OF LEUKEMIC AND HEALTHY STEM CELLS

EHA Library, Martin Culen, 99830

MICROVESICLES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Giovanni D'Arena, 99831

CHANGES IN LYMPHOCYTE SUBSETS, ANGIOGENIC FACTORS AND PLASMA CYTOKINES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA DURING TREATMENT WITH OFATUMUMAB AND LENALIDOMIDE

EHA Library, Candida Vitale, 99832

THE ROLE OF MICRORNAS IN RESPONSE TO NEW TARGETED THERAPIES IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento, 99833

QUANTITATIVE AND QUALITATIVE ANALYSIS OF REGULATORY T CELLS (TREGS) IN B CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)

EHA Library, Vasiliki Pappa, 99834

FCGAMMARIIB HOMMOAGREGATION CAN INDUCE A PROSURVIVAL STATE IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS

EHA Library, Rosa Bosch, 99835

CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE HIGHLY SUSCEPTIBLE TO DIRECT INHIBITION OF CHECKPOINT KINASE 1

EHA Library, Jana Zemanova, 99836

TYROSINE KINASE INHIBITOR THERAPY INDUCES ALTERATIONS OF CD137 AND CD137L EXPRESSION IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Paulo Rodrigues-Santos, 99837

METABOLIC CHARACTERISTICS OF IMATINIB RESISTANT CHRONIC MYELOID LEUKEMIA WITH T315I MUTATION

EHA Library, Jun Young Heo, 99838

DISCOVERING ALTERNATIVE TARGETS IN CHRONIC MYELOID LEUKEMIA (CML): DETERMINATION OF EXPRESSION LEVELS OF BIOACTIVE SPHINGOLIPID GENES IN NEWLY DIAGNOSED AND DRUG-RESISTANT CML PATIENTS

EHA Library, Melis Kartal Yandim, 99839

COMPARISON OF TYROSINE-KINASE INHIBITORS AS FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKEMIA: RESULTS OF A NETWORK META-ANALYSIS INCLUDING 6314 PATIENTS

EHA Library, Nicole Skoetz, 99840

IMMUNOPHENOTYPE OF CLL CASES WITH STEREOTYPED BCR IS CHARACTERIZED BY DECREASED CD23 EXPRESSION

EHA Library, Vladimir Strugov, 99841

FREQUENCY OF CLL-LIKE MONOCLONAL B LYMPHOCYTOSIS IN JAPANESE PEOPLE LIVING IN SAO PAULO, BRAZIL

EHA Library, Mariane Ferreirade, 99842

EVALUATION OF A QUANTITATIVE MULTIPLEX BCR-ABL1 ASSAY ALIGNED DIRECTLY TO THE WHO PRIMARY STANDARD REFERENCE MATERIALS TO REPORT EXPRESSION ON THE INTERNATIONAL SCALE

EHA Library, Justin Brown, 99843

OUTCOMES OF ANTICOAGULANT OR ANTIPLATELET USE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR INDOLENT NON-HODGKIN’S LYMPHOMA IN IDELALISIB TRIALS

EHA Library, Peter Hillmen, 99844

ESTIMATED GLOMERULAR FILTRATION RATES OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS (TKIS) IN DASATINIB TRIALS: DASISION (CA180-056), CA180-034, AND CA180-035

EHA Library, Jorge Cortes, 99845

EFFICACY OF NILOTINIB VS HIGH-DOSE IMATINIB VS SUSTAINING STANDARD-DOSE IMATINIB IN EARLY CHRONIC PHASE CML PATIENTS WHO HAVE SUBOPTIMAL MOLECULAR RESPONSE TO FRONTLINE IMATINIB

EHA Library, Soo Young Choi, 99847

MINIMAL RESIDUAL DISEASE IN HAIRY CELL LEUKEMIA: DOES IT MATTER?

EHA Library, Abel Santos Carreira, 99848

LONG-TERM BOSUTINIB FOR PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ADVANCED CHRONIC MYELOID LEUKEMIA (CML) AFTER PRIOR TYROSINE KINASE INHIBITOR FAILURE

EHA Library, Carlo Gambacorti-Passerini, 99849

TWO DECADES OF SINGLE-CENTER EXPERIENCE REGARDING THE TREATMENT, PREDICTORS OF SURVIVAL AND CAUSES OF DEATH IN PATIENTS WITH HAIRY CELL LEUKEMIA

EHA Library, Danijela Lekovic, 99850

EVALUATION OF A CENTRALIZED MOLECULAR MONITORING OF CHRONIC MYELOID LEUKEMIA THERAPY IN SOUTH KOREA

EHA Library, Soo Young Choi, 99851

COMPARATIVE ANALYSIS OF BCR-ABL AND VEGFR2 INHIBITORY ACTIVITIES OF PONATINIB, AXITINIB, AND PF-114

EHA Library, Joseph M Gozgit, 99852

MULTICENTER STUDY OF COMORBIDITY IN CANARIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Maria Saez-Perdomo, 99853

THE RATE OF BCR-ABL DECLINE AS AN OPTIMIZED PREDICTOR OF OUTCOME FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE ON TREATMENT WITH TYROSINE KINASE INHIBITORS

EHA Library, Aleksandr Fomin, 99854

A STUDY OF CELL CYCLE KINETICS AND OF KU80 EXPRESSION AS A MARKER OF GENETIC INSTABILITY IN BONE MARROW MESENCHYMAL STEM CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Vasiliki Papadopoulou, 99855

BCR-ABL EXPRESSION IS REDUCED IN THE PRIMITIVE PRECURSOR FRACTION FROM CML TKI-TREATED PATIENTS.

EHA Library, Maria Sol Ruiz, 99856

EFFICACY AND SAFETY FOR DASATINIB IN EARLY CHRONIC PHASE CML PATIENTS WITH LATE SUBOPTIMAL RESPONSE TO FRONTLINE IMATINIB. PRELIMINARY RESULTS FROM DASAPOST STUDY

EHA Library, Valentin Garcia-Gutierrez, 99857

SELECTION OF RUNX1-MUTATED CLONE ASSOCIATED WITH RELAPSE AND BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA PATIENT AFTER ALLO-HSCT AS REVEALED BY TARGETED ENRICHMENT AND DEEP SEQUENCING

EHA Library, Iwona Solarska, 99858

NANOPORE SEQUENCING TO RAPIDLY CHARACTERISE LEUKEMIA-SPECIFIC GENOMIC TRANSLOCATION BREAKPOINTS

EHA Library, Andrew Chase, 99859

MISSPLICED GSK3Β TRANSCRIPT IS UNIVERSALLY EXPRESSED AND CANNOT BE USED TO PREDICT BLAST CRISIS TRANSFORMATION IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Lihui Wang, 99860

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: REVIEW OF 28 CASES

EHA Library, Lucia Guerrero Fernandez, 99861

PREDICTIVE FACTORS FOR TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH IMATINIB-TREATED, UNDETECTABLE MOLECULAR RESIDUAL DISEASE: RESULTS FROM THE KID STUDY

EHA Library, Sung-Eun Lee, 99862

ASSESSING RISK FACTORS OF ELECTRONICALLY MEASURED MEDICATION NON-ADHERENCE IN CML PATIENTS: AN OBSERVATIONAL LONGITUDINAL DESIGN– A SUBANALYSIS OF THE TAKE-IT STUDY

EHA Library, Avi Leader, 99863

A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Michele Baccarani, 99864

IDENTIFICATION OF PREDICTIVE MARKERS OF IMMUNO-SENESCENCE WITH FOCUS ON TUMOR SUPPRESSIVE GENES: HEALTHY DONORS VERSUS PATIENTS DIAGNOSED WITH A LYMPHOPROLIFERATIVE DISEASE

EHA Library, Dominique BRON, 99865

CHRONIC EXPOSURE TO INTERFERON-ALPHA DRIVES MEDULLAR LYMPHOPOIESIS TOWARDS T CELL DIFFERENTIATION IN MICE

EHA Library, Marianna Di Scala, 99866

IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE: CURRENT INCIDENCE OF CYTOGENETIC REMISSION AND A VERY LONG-TERM AN INTENTION-TO-TREAT ANALYSIS

EHA Library, Oleg Shukhov, 99868

CORD BLOOD STEM CELLS BUT NOT ADULT STEM CELLS AFTER TRANSPLANTATION OVEREXPRESS STEMNESS AND REPROGRAMMING GENES PARTIALLY OVERLAPPING THE SIGNATURE OF INDUCED PLURIPOTENT STEM CELLS (IPS)

EHA Library, Daniela Cilloni, 99869

STROMAL CELL-DERIVED FACTOR-1 PLAYS IMPORTANT ROLES IN THE REGULATION OF HUMAN EARLY B- AND T/NK-LINEAGE LYMPHOID DIFFERENTIATION IN DIFFERENT MANNERS

EHA Library, Hirohito Minami, 99870

COMPARISON OF SELF-RENEWAL EXPRESSION IN STROMAL IN VITRO AND IN VIVO MICROENVIRONMENT MODELS – CRITICAL DIFFERENCES AND THEIR IMPACT ON HEMATOPOIETIC SUPPORT FUNCTIONS

EHA Library, Gillian Horne, 99871

OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%≤ AND >10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

EHA Library, Ahmet Emre Eskazan, 99872

EXPRESSION OF PD-I LIGANDS FOR CLASSICAL HODGKIN LYMPHOMA PROGNOSIS

EHA Library, Iryna Kriachok, 99873

PATIENT CHARACTERISTICS AND ADVERSE EVENTS (AES) OF TYROSINE KINASE INHIBITORS (TKIS) FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN REAL WORLD SETTINGS

EHA Library, Stuart L. Goldberg, 99874

THE EFFECT OF NILOTINIB IN CHRONIC MYELOID LEUKEMIA TREATMENT DOSE ON FERTILITY AND TERATOGENICITY IN A HEALTHY MOUSE MODEL

EHA Library, Guldane Seval, 99875

DYNAMICS OF RESPONSE AND IMPACT OF SOKAL SCORE IN 3 MONTHS MOLECULAR 'WARNING' CML PATIENTS. A RETROSPECTIVE STUDY OF GRUPPO TRIVENETO LMC.

EHA Library, gianni binotto, 99876

AUTOMATED IMAGE ANALYSIS REVEALED A HIGH VARIABILITY OF CD30+ HRS CELLS DENSITY IN CLASSICAL NODULAR SCLEROSIS HODGKIN LYMPHOMA

EHA Library, Eva Kriegová, 99877

HODGKIN LYMPHOMA PATIENTS WITH HIGH NUMBER OF MACROPHAGES IN TUMOR TISSUE - RISK PROFILE AND TREATMENT OUTCOME

EHA Library, Bosko Andjelic, 99878

IMATINIB TREATMENT DURATION EFFECT ON ESTIMATED GLOMERULAR FILTRATION RATE IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Lenka Ruzickova, 99879

FLUDARABINE TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA-ASSOCIATED NEUROPATHY – 20 YEARS EXPERIENCE OF A SINGLE CENTER

EHA Library, Sinziana Radesi - Sarghi, 99880

HYPOGAMMAGLOBULINEMIA AT LONG-TERM AFTER RITUXIMAB/CHEMOTHERAPY TREATMENT FOR LYMPHOMA, AND USE OF INTRAVENOUS IMMUNOGLOBULINS FOR RECURRENT INFECTIONS.

EHA Library, Mariana Ferraro, 99881

EFFICACY AND SAFETY OF DASATINIB VS. IMATINIB IN LATIN AMERICAN SUBPOPULATION FROM THE DASISION TRIAL IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP)

EHA Library, Alicia Enrico, 99882

THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPAŞA CML COHORT

EHA Library, Ahmet Emre Eskazan, 99883

CIRCULATING ADAMTS-13 IS REDUCED IN PATIENTS WITH WALDENSTROM'S MACROGLOBULINEMIA AND IS ASSOCIATED WITH INCREASED IGM LEVELS AND DISEASE FEATURES BUT NOT WITH THE LEVELS OF VON WILLEBRAND FACTOR

EHA Library, Efstathios Kastritis, 99884

ANALYSIS OF THE RELATIONSHIP BETWEEN DOSE AND BCR-ABL HALVING TIME IN CP-CML PATIENTS TREATED WITH PONATINIB OR IMATINIB

EHA Library, Justin Pritchard, 99885

CAR MEDIATES DIFFERENTIATION AND MIGRATION OF ERYTHROPOIETIC PROGENITOR CELLS AND IS SPECIFICALLY DOWN-REGULATED IN MDS

EHA Library, Karin Bauer, 99886

RUNX1 MUTATION AND LOW RUNX1 TRANSACTIVATING ACTIVITY PREDICT HIGHER RISK OF AML TRNASFORMATION AND INFERIOR LEUKEMIA-FREE SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Ming-Chung Kuo, 99887

ABNORMAL MONOCYTE POPULATIONS IN THE PERIPHERAL BLOOD OF PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Maria Velegraki, 99888

GLUTATHIONE S-TRANSFERASE P1 (GSTP1) PROMOTER HYPERMETHYLATION IN MDS/AML: ASSOCIATION WITH SPECIFIC CHROMOSOME ABBERATIONS

EHA Library, Constantina Sambani, 99889

RITUXIMAB WITH OR WITHOUT CHLORAMBUCIL FOR THE TREATMENT OF EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA: RESULTS OF A MONOCENTRIC STUDY.

EHA Library, Luigi Rigacci, 99890

IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE “IN VIVO” HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX

EHA Library, Daniela Cilloni, 99891

INDUCTION PHASE INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND IMPACT OF STEROID DOSE ON THE INCIDENCE OF INFECTIONS: A RANDOMIZED CONTROLLED STUDY

EHA Library, Turan Bayhan, 99892

AUTOPHAGY LEVEL WAS ABNORMAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Huaquan Wang, 99893

VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN WITH MALIGNANCY: ISTANBUL PERSPECTIVE

EHA Library, Zeynep Karakas, 99894

PROGNOSTIC AND PREDICTIVE VALUE OF IPSS-R IN ASSESSING OVERALL SURVIVAL (OS) IN A PHASE III STUDY OF RIGOSERTIB IN SECOND-LINE HIGHER-RISK (HR) MDS PATIENTS

EHA Library, Lewis Silverman, 99895

INCREASED IMMUNE ACTIVATION AND IMPAIRED CELL SUPPRESSION ON MYELODYSPLASTICS SYNDROMES PROGRESSION

EHA Library, Aline Perazzio, 99896

IMMUNE EXACERBATION ON MYELODYSPLASTICS SYNDROMES

EHA Library, Aline Perazzio, 99897

BIOSIMILAR FILGRASTIM IN PATIENTS UNDERGOING NEUTROPENIA-INDUCING CHEMOTHERAPY: OVERALL RESULTS FROM THE NEXT OBSERVATIONAL STUDY

EHA Library, Frederic Maloisel, 99898

ORGANIZING PNEUMONIA IN HEMATO-ONCOLOGY PATIENTS: A SOMEWHAT DISREGARDED DIFFERENTIAL DIAGNOSIS

EHA Library, Gil Brás, 99899

INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: REPORT FROM A SINGLE CENTER

EHA Library, Angela Maria Quinto, 99900

RABBIT ANTITHYMOCYTE GLOBULIN AT > 3,5 MG/KG/DAY/X 5 DAYS FOR TREATMENT OFACQUIRED APLASTIC ANEMIA

EHA Library, Juan Carlos Vallejo Llamas, 99901

ANIDULAFUNGIN THERAPY FOR HIGH RISK OF INVASIVE FUNGAL INFECTION HEMATOLOGIC PATIENTS: ITS ROLE IN REAL-LIFE SINGLE CENTER EXPERIENCE.

EHA Library, Sara Lozano, 99902

LOW-RISK MYELODYSPLASTIC PATIENTS SUPPORTED WITH ERYTHROPOIETIN PLUS LIPOSOMIAL IRON SHOWS A REDUCED NUMBER OF FEBRILE EPISODES THAN PATIENTS WITH INTRAVENOUS IRON SUPPORT.

EHA Library, GIULIO GIORDANO, 99903

RISK FACTORS FOR FEBRILE NEUTROPENIA AND BLOODSTREAM INFECTIONS IN RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTS

EHA Library, Igor Stoma, 99904

ANALYSIS OF 75 CASES OF ACUTE LEUKEMIA WITH INVASIVE FUNGAL DISEASE

EHA Library, Ye-Hui Tan, 99905

LOOKING FOR HYPOXIA FINGERPRINT IN MALIGNANT PLASMA CELL APPLIED TO NORMOXIC ENVIRONMENT.

EHA Library, Kinga Kocemba, 99906

IN HOUSE NEXT GENERATION SEQUENCING METHOD OF INMUNOGLOBULIN GENES FOR MINIMAL RESIDUAL DISSEASE QUANTIFICATION IN MULTIPLE MYELOMA

EHA Library, Joaquin Martinez-Lopez, 99907

NOCARDIA INFECTION IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Maria Stamouli, 99908

INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE

EHA Library, Sofia Ramos, 99909

VARIOUS PATTERNS OF HEPATITIS B VIRUS REACTIVATION IN B CELL LYMPHOMA

EHA Library, Aya Nakaya, 99910

PERSONAL HISTORY OF INFECTIONS ASSOCIATED WITH AN INCREASED RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AND MULTIPLE MYELOMA: A POPULATION-BASED NESTED CASE-CONTROL STUDY

EHA Library, Charlene McShane, 99911